Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4787287 | 5897266 | I | 4787287-0 | 20050916 | 20050930 | EXP | 12445 | MAYNE PHARMA PTY LTD. | F | N | 20050930 | MD | CANADA |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4787287 | 1006480337 | PS | PAMIDRONATE DISODIUM | 1 | D | D | 75841 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 4787287 | 1006480337 | OSTEOGENESIS IMPERFECTA |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 4787287 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 4787287 | BLOOD ALKALINE PHOSPHATASE INCREASED |
| 4787287 | BLOOD PARATHYROID HORMONE DECREASED |
| 4787287 | BLOOD PHOSPHORUS INCREASED |
| 4787287 | DRUG EXPOSURE DURING PREGNANCY |
| 4787287 | MATERNAL CONDITION AFFECTING FOETUS |
| 4787287 | OSTEOGENESIS IMPERFECTA |
| 4787287 | SCLERAL DISCOLOURATION |
| 4787287 | TALIPES |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 4787287 | FGN |
| 4787287 | HP |
| 4787287 | LIT |
| 4787287 | OTH |
Therapies reported
| no results found |